switching from tirzepatide to semaglutide for weight loss Early Dose Escalation of after in Type 2 Diabetes Mellitus Switch from Tirzepatide to Semaglutide:
Description
That dual mechanism, reduced input plus increased output, explains the dramatic differences in clinical trial results
Moreover, our findings indicate that the endocrine pancreas is also an important source of GLP-1 targeted by DPP-4 inhibitors to confer better glucose tolerance
Lancet 402, 203234 (2023)
For safety and successful outcomes, these treatments must be accompanied by comprehensive wrap-around care which includes dietary, behavioural, and medical support
Interestingly, the DRN has also been implicated as a significant regulator of body weight and feeding [27]
